Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-26 @ 12:46 AM
Study NCT ID:
NCT03571360
Status:
UNKNOWN
Last Update Posted:
2020-06-11
First Post:
2018-06-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
CTA Expression/Methylation and Response to Pembrolizumab of NSCLC Patients
Sponsor:
Medical University of Vienna
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-14
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-07-14
Completion Date Type:
ESTIMATED
First Submit Date:
2018-06-12
First Submit QC Date:
None
Study First Post Date:
2018-06-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-09
Last Update Post Date:
2020-06-11
Last Update Post Date Type:
ACTUAL